BR0113296A - Processo para a preparação de sais de peptìdeos, seu uso e preparações farmacêuticas contendo os sais de peptìdeos - Google Patents

Processo para a preparação de sais de peptìdeos, seu uso e preparações farmacêuticas contendo os sais de peptìdeos

Info

Publication number
BR0113296A
BR0113296A BR0113296-2A BR0113296A BR0113296A BR 0113296 A BR0113296 A BR 0113296A BR 0113296 A BR0113296 A BR 0113296A BR 0113296 A BR0113296 A BR 0113296A
Authority
BR
Brazil
Prior art keywords
peptide salts
pharmaceutical preparations
preparation
preparations containing
peptide
Prior art date
Application number
BR0113296-2A
Other languages
English (en)
Inventor
Michael Damm
Waldemar Salonek
Juergen Engel
Horst Bauer
Gabriele Stach
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27805895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0113296(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of BR0113296A publication Critical patent/BR0113296A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DE SAIS DE PEPTìDEOS, SEU USO E PREPARAçõES FARMACêUTICAS CONTENDO OS SAIS DE PEPTìDEOS". A invenção refere-se a preparações farmacêuticas contendo sal de peptídeo, a sua preparação e ao seu uso. A invenção refere-se particularmente a preparações farmacêuticas contendo um sal de difícil solubilidade de agonistas ou antagonistas LHRH, tais como embonato de Cetrorelix, para a aplicação parenteral em mamíferos com efeito prolongado.
BR0113296-2A 2000-08-17 2001-08-09 Processo para a preparação de sais de peptìdeos, seu uso e preparações farmacêuticas contendo os sais de peptìdeos BR0113296A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10040700A DE10040700A1 (de) 2000-08-17 2000-08-17 Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung
PCT/EP2001/009219 WO2002014347A2 (de) 2000-08-17 2001-08-09 Verfahren zur herstellung von peptidsalzen, deren verwendung und die peptidsalze enthaltende pharmazeutische zubereitungen
CA002355573A CA2355573A1 (en) 2000-08-17 2001-08-22 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts

Publications (1)

Publication Number Publication Date
BR0113296A true BR0113296A (pt) 2003-07-15

Family

ID=27805895

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113296-2A BR0113296A (pt) 2000-08-17 2001-08-09 Processo para a preparação de sais de peptìdeos, seu uso e preparações farmacêuticas contendo os sais de peptìdeos

Country Status (30)

Country Link
US (1) US6780972B2 (pt)
EP (1) EP1309607B1 (pt)
JP (1) JP2004506647A (pt)
CN (1) CN1187369C (pt)
AR (1) AR030371A1 (pt)
AT (1) ATE280779T1 (pt)
AU (2) AU2002210439B2 (pt)
BG (1) BG107612A (pt)
BR (1) BR0113296A (pt)
CA (1) CA2355573A1 (pt)
CZ (1) CZ2003688A3 (pt)
DE (2) DE10040700A1 (pt)
DK (1) DK1309607T3 (pt)
EE (1) EE200300065A (pt)
ES (1) ES2230371T3 (pt)
HK (1) HK1058366A1 (pt)
HU (1) HUP0300738A3 (pt)
IL (1) IL154150A0 (pt)
MX (1) MXPA03001448A (pt)
NO (1) NO20030618L (pt)
NZ (1) NZ524023A (pt)
PL (1) PL204496B1 (pt)
PT (1) PT1309607E (pt)
RU (1) RU2266296C2 (pt)
SI (1) SI1309607T1 (pt)
SK (1) SK3032003A3 (pt)
TW (1) TWI236910B (pt)
UA (1) UA74005C2 (pt)
WO (1) WO2002014347A2 (pt)
ZA (1) ZA200300777B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
EP1674082A1 (de) * 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
RU2525661C2 (ru) * 2012-11-15 2014-08-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" Российской академии медицинских наук (ФГБУ "НИИВС им. И.И. Мечникова" РАМН) Способ получения высокотитражной антимикробной сыворотки для оценки антигенной активности противостафилококковых вакцин
CN107056894B (zh) * 2017-05-26 2021-07-20 济南康和医药科技有限公司 一种片段法固相合成醋酸加尼瑞克的方法
EP3590526A1 (en) * 2018-07-05 2020-01-08 Antev Limited A lyophilization process and a teverelix-tfa lyophilizate obtained thereby

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431635A (en) * 1979-06-13 1984-02-14 Coy David Howard LH-RH Antagonists
DE3165535D1 (en) * 1980-06-02 1984-09-20 Andrew Victor Schally Lh-rh antagonists
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
EP0626170A3 (en) * 1993-05-10 1996-03-27 Sandoz Ltd Stabilization of pharmacoligically active compounds in controlled release compositions.
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
DE4342092B4 (de) * 1993-12-09 2007-01-11 Zentaris Gmbh Langwirkende Injektionssuspension und Verfahren zur Herstellung
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
RU2230550C2 (ru) * 1998-01-16 2004-06-20 Такеда Кемикал Индастриз, Лтд. Композиции длительного высвобождения, способ их получения и применение

Also Published As

Publication number Publication date
PL204496B1 (pl) 2010-01-29
AU1043902A (en) 2002-02-25
UA74005C2 (en) 2005-10-17
SK3032003A3 (en) 2004-05-04
WO2002014347A2 (de) 2002-02-21
EP1309607A2 (de) 2003-05-14
DK1309607T3 (da) 2005-01-17
NO20030618D0 (no) 2003-02-07
ES2230371T3 (es) 2005-05-01
NZ524023A (en) 2004-11-26
HK1058366A1 (en) 2004-05-14
NO20030618L (no) 2003-02-07
SI1309607T1 (en) 2005-02-28
PL359495A1 (en) 2004-08-23
AR030371A1 (es) 2003-08-20
PT1309607E (pt) 2005-02-28
BG107612A (bg) 2003-12-31
RU2003107560A (ru) 2005-01-27
AU2002210439B2 (en) 2005-10-20
HUP0300738A2 (hu) 2003-09-29
EE200300065A (et) 2004-12-15
TWI236910B (en) 2005-08-01
DE10040700A1 (de) 2002-02-28
JP2004506647A (ja) 2004-03-04
DE50104316D1 (de) 2004-12-02
ATE280779T1 (de) 2004-11-15
EP1309607B1 (de) 2004-10-27
MXPA03001448A (es) 2004-12-13
HUP0300738A3 (en) 2004-08-30
US6780972B2 (en) 2004-08-24
CN1187369C (zh) 2005-02-02
ZA200300777B (en) 2003-09-18
CZ2003688A3 (cs) 2004-03-17
RU2266296C2 (ru) 2005-12-20
IL154150A0 (en) 2003-07-31
CA2355573A1 (en) 2003-02-22
WO2002014347A3 (de) 2002-08-08
US20020198146A1 (en) 2002-12-26
CN1447817A (zh) 2003-10-08

Similar Documents

Publication Publication Date Title
NL300281I2 (nl) Exenatide, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
HRP20020880B1 (en) New pharmaceutical composition
AR021074A1 (es) COMPOSICIoN FARMACÉUTICA DE MOXIFLOXACINA, PROCEDIMIENTO PARA SU PRODUCCIoN, Y USO DE DICHA COMPOSICIoN PARA PREPARAR UN MEDICAMENTO ANTIBACTERIANO.
NO317747B1 (no) Farmasoytisk preparat samt anvendelse derav
BR9811094A (pt) Agente terapêutico para tumores linfáticos
BR0107246A (pt) Agentes diazabicìclicos ativos no sistema nervoso central
BR0316234A (pt) Hidroxiindóis, seu uso como inibidores de fosfodiesterase 4 e processos para a preparação dos mesmos
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
BR9713734A (pt) Derivados de sulfonamidas, processo para sua preparação, e seu uso como medicamentos
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
BR0009678A (pt) Compostos, composição farmacêutica, e, uso de compostos
WO2004060393A3 (fr) Activateur cutane associant de l’atp avec d’autres bio-molecules a effet metabolique.
ES2171086T3 (es) Uso de proteinas hmg para la preparacion de medicamentos con actividad citotoxica.
DE69929703D1 (de) Neue orale formulierungen für 5-ht4 agonisten oder antagonisten
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
BR0113296A (pt) Processo para a preparação de sais de peptìdeos, seu uso e preparações farmacêuticas contendo os sais de peptìdeos
DK0833640T3 (da) Farmaceutisk præparat indeholdende lamotrigin
BR9801132A (pt) N-heterociclos fundidos, substituìdos com benzilóxi, processo para a sua preparação e seu uso como antagonistas de receptor de bradiquinina.
BR0208169A (pt) Composto quìmicos
BR0007686A (pt) Uso de antagonistas receptores da angiotensina ii para tratar enfartação miocárdia aguda
EA199900750A1 (ru) Водная фармацевтическая композиция, включающая активный ингредиент, в высшей степени нерастворимый в воде
BR9809457A (pt) Sais de peptìdeo de bpc com atividade organo-protetora, o processo para sua preparação e seu uso em terapia.
ATE301194T1 (de) Beta-defensine
SE8502540L (sv) Stabilt tandvardsmedel innehallande dextranas
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BLITZ F02-570 GMBH (DE)

Free format text: TRANSFERIDO POR FUSAO DE: ZENTARIS AG

B25D Requested change of name of applicant approved

Owner name: ZENTARIS GMBH (DE)

Free format text: ALTERADO DE: BLITZ F02-570 GMBH

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: ZENTARIS GMBH (DE)

Free format text: SEDE ALTERADA CONFORME PETICAO NO 020060058923-RJ DE 27.04.2006.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2156 DE 02/05/2012.